MedDataX Logo

Amniotic Fluid Sludge in Cerclage Patients as an Indicator for Increased Risk of Preterm Delivery and Neonatal Outcome.

NCT ID: NCT00722085

Last Updated: 2008-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

177 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-01-31

Study Completion Date

2008-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Amniotic Fluid "Sludge" Does Not Increase Risk of Preterm Delivery in Cerclage Patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

177 patients were selected from a data base of 1890. 60 patients had sludge, 117 did not have sludge. Conclusion AF sludge on ultrasound had no association with increased risk of preterm delivery in patients with cerclage.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

High Risk Pregnancy Incompetent Cervix Cerclage Amniotic Fluid Sludge Gestation Age at Delivery.

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Amniotic Fluid Sludge Cerclage Ultrasound Preterm Delivery Neonatal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cerclage
* Pregnancy Outcome data available
* Neonatal Outcome data available
* Pre and Post Cerclage Cervical length measurements
* Hx of cervical procedures, if any, available

Exclusion Criteria

* Cervical ultrasound picture(s) unacceptable
* Any missing maternal or fetal data as stated above
* Fetal anomaly
* Cervical dilation at time of cerclage
* Placental previa or abruption
* Preterm Labor
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Center For Maternal Fetal Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Center For Maternal Fetal Medicine

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laura A Gorski, D.O.

Role: PRINCIPAL_INVESTIGATOR

Center For Maternal Fetal Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Center For Maternal Fetal Medicine

Las Vegas, Nevada, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1096165

Identifier Type: -

Identifier Source: org_study_id